Repatha (evolocumab) is a brand-name subcutaneous injection that isn’t known to interact with alcohol, other drugs, or supplements. However, Repatha has health-related interactions that are ...

Like fellow Big Pharmas Eli Lilly and Johnson & Johnson, Amgen is urging the Trump administration to consider tax policy ...

But, in the long run, it could still be much more affordable than lifelong repetitive Repatha injections. And remember, HeFH is a potentially huge TAM for VERV as it's projected to reach up to $32 ...

Repatha generated revenues of $656.0 million ... Zepbound and Wegovy, which are weekly injections. In March, Amgen initiated two phase III studies on MariTide in obesity as part of its ...

and Sanofi/Regeneron’s Repatha (alirocumab) – but these require subcutaneous injection every two to four weeks. Sales of both the commercially available antibodies have failed to live up to ...

Kalamazoo resident Suzette Ross, who relies on three cardiac medications including the injectable drug Repatha ... m very concerned about that one. Each injection is almost $300,” Ross said.

General Medicine remains the most profitable — these are Repatha and Evenity ... supported by products like Otezla — a pill, not an injection, and this is already winning a part of the ...

Amgen AMGN reported first-quarter 2025 adjusted earnings of $4.90 per share, which beat the Zacks Consensus Estimate of $4.16 ...

Sanofi and Regeneron have scored a major victory in their fight with Amgen in the market for cardiovascular drugs, after releasing data showing their Praluent injection reduces risk of ...